Stimulant Dependence

Cocaine, Methamphetamine &

Prescription Stimulants

David A.N. Siegel, MD

Confidential & Discreet

How It Begins

It may produce a clarity the mind has rarely found on its own. It may open something that had always been closed — a feeling of capability, of engagement, of actually being here. For some people, what a stimulant provides is not simply a good feeling. It is closer to the experience of becoming available to oneself. That is often where serious dependence begins: not in excess or indulgence, but in the discovery of something that felt genuinely necessary. Whether that discovery arrived through a prescription or outside one changes nothing about what the brain has done with it.

What Stimulants Do to the Brain

Part of what makes that feel so true — and what makes it so difficult to leave behind — is what the drug has done to the brain's own reward system.

Stimulants — cocaine, methamphetamine, and prescription medications like Adderall and Ritalin — produce their effects by flooding the brain's core reward circuitry with dopamine at levels the brain's own systems cannot approach.

Normally, dopamine works in two distinct ways: brief sharp bursts tied to specific rewards that drive motivation and learning, and a steady background level that sets the general tone of the reward system. Stimulants collapse this distinction, flooding the entire system indiscriminately. With chronic use, the brain makes multiple compensatory adaptations — in how much dopamine it releases, in receptor availability, in how the transporter system functions — that collectively leave the system underresponsive to stimulation.

The consequence is a reward system that can no longer respond adequately to ordinary experience. This is the biological basis of the withdrawal period — and one of the central reasons stimulant dependence is difficult to break.

Withdrawal and Its Aftermath

Stimulant withdrawal produces a prolonged period of profound fatigue, low mood, cognitive slowing, and an inability to experience pleasure — as the dopamine system slowly reorganizes itself. This is often more disabling than people anticipate, and it can persist for a year or more.

It is also a primary driver of relapse. The pace of the taper determines how much of that the person has to bear at once. When reduction moves faster than the nervous system can readjust, the distress becomes severe enough to threaten treatment. A slow taper allows the dopamine system to adjust incrementally rather than forcing a collapse.

How I Approach It

There is no direct pharmacological substitute for stimulants — no equivalent of Suboxone for opioids. But stimulants can and should be tapered, not stopped abruptly. A managed taper — gradual, medically supervised, calibrated to the individual — allows the dopamine system to begin readjusting without breakdown.

The broader work has a particular character in stimulant dependence. Most substances regulate — they modulate states that already exist. What stimulants produce, for many of the people who become dependent on them, is something different: not a modification of a state they already knew, but the arrival of a self that feels present, capable, and real in a way nothing else had delivered. The dependency is not only on the drug. It is on that version of themselves.

What the ongoing work addresses is what that experience was for — what had been absent or inaccessible, and what it might take to find something that can be carried rather than borrowed. What the treatment relationship offers, over time, is the experience of having that interior taken seriously.

Frequently Asked Questions

Q: What stimulants do you treat?

A: Cocaine, methamphetamine, and prescription stimulants including Adderall and Ritalin. The mechanisms of dependence share important features across these substances, though the clinical picture differs and treatment is individualized accordingly.

Q: Does treatment require a facility or residential program?

A: No. Treatment is entirely outpatient and private. There is no facility, no program, and no requirement that anyone else know you are in treatment.

Q: I’m currently being prescribed stimulants by another doctor. Does that affect getting in touch?

A: No. Many people in this situation are still under the care of the physician who originally prescribed the medication. Nothing about an initial conversation creates any obligation. If treatment moves forward, it would mean working with one physician rather than two — having both managing overlapping treatment creates unnecessary risks.

Q: I’m concerned that I won’t be able to function without the medication.

A: That concern is worth taking seriously — and it is part of what treatment works to understand. What the medication has been providing, and what that means for you, is a central question, not an afterthought. The taper is designed to be gradual enough that disruption to daily life and work is minimized throughout.

Q: I have ADHD. Does getting off stimulants mean it goes untreated?

A: No. ADHD and stimulant dependence are separate, but related conditions — both taken on their own terms, neither collapsed into the other. Stimulants have become so closely associated with ADHD that they are often treated as synonymous with its treatment. They are not. There are effective approaches to managing ADHD that do not involve stimulant medications, and identifying the right one is part of the work. The goal is not to leave the underlying condition unaddressed — it is to address it without continuing the dependence.

Q: How long does treatment take?

A: Treatment is personalized and has no fixed endpoint. Duration is determined by what each person actually needs — medically and psychologically.

Getting in Touch

The first conversation is free and completely confidential. There is no obligation of any kind.

Call me directly: (646) 418-7077